Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OBLN

Obalon Therapeutics

$1.83

(0.00%)

, APEN

Apollo Endosurgery

$3.28

-0.27 (-7.61%)

14:15
01/14/19
01/14
14:15
01/14/19
14:15
Conference/Events
Piper Jaffray medical devices analyst to hold analyst/industry conference call »

Medical Devices Analyst…

OBLN

Obalon Therapeutics

$1.83

(0.00%)

APEN

Apollo Endosurgery

$3.28

-0.27 (-7.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 18

    May

OBLN

Obalon Therapeutics

$1.82

-0.01 (-0.55%)

, APEN

Apollo Endosurgery

$3.26

-0.29 (-8.17%)

10:43
01/14/19
01/14
10:43
01/14/19
10:43
Conference/Events
Piper Jaffray medical devices analyst to hold analyst/industry conference call »

Medical Devices Analyst…

OBLN

Obalon Therapeutics

$1.82

-0.01 (-0.55%)

APEN

Apollo Endosurgery

$3.26

-0.29 (-8.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

APEN

Apollo Endosurgery

$3.45

-0.08 (-2.27%)

08:27
01/02/19
01/02
08:27
01/02/19
08:27
Upgrade
Apollo Endosurgery rating change at Northland »

Apollo Endosurgery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

Over a month ago
APEN

Apollo Endosurgery

$3.30

0.03 (0.92%)

16:17
12/21/18
12/21
16:17
12/21/18
16:17
Hot Stocks
Neil Gagnon reports 5.29% passive stake in Apollo Endosurgery »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$3.57

0.08 (2.29%)

14:27
12/18/18
12/18
14:27
12/18/18
14:27
Recommendations
Apollo Endosurgery analyst commentary at Craig-Hallum »

Craig-Hallum says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$3.57

0.08 (2.29%)

12:45
12/18/18
12/18
12:45
12/18/18
12:45
Recommendations
Apollo Endosurgery analyst commentary at Piper Jaffray »

Apollo Endosurgery target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$3.49

-0.42 (-10.74%)

, RSLS

ReShape Lifesciences

$0.41

-0.098 (-19.22%)

08:09
12/18/18
12/18
08:09
12/18/18
08:09
Hot Stocks
Apollo Endosurgery sells surgical product line to ReShape Lifesciences »

Apollo Endosurgery (APEN)…

APEN

Apollo Endosurgery

$3.49

-0.42 (-10.74%)

RSLS

ReShape Lifesciences

$0.41

-0.098 (-19.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APEN

Apollo Endosurgery

$4.02

0.57 (16.52%)

16:01
11/27/18
11/27
16:01
11/27/18
16:01
Hot Stocks
Apollo Endosurgery announces first commercial shipment of OverStitch system »

Apollo Endosurgery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

APEN

Apollo Endosurgery

$5.81

-0.29 (-4.75%)

06:56
11/09/18
11/09
06:56
11/09/18
06:56
Downgrade
Apollo Endosurgery rating change at Northland »

Apollo Endosurgery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

APEN

Apollo Endosurgery

$5.81

-0.29 (-4.75%)

16:01
11/08/18
11/08
16:01
11/08/18
16:01
Earnings
Apollo Endosurgery reports Q3 EPS (45c), consnesus (35c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 15

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.